Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva b.v. - ezetimibe 10 mg; atorvastatin calcium trihydrate 43,38 mg - eq. atorvastatin 40 mg - film-coated tablet - 10 mg - 40 mg - ezetimibe 10 mg; atorvastatin calcium trihydrate 43.38 mg - atorvastatin and ezetimibe

Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva b.v. - ezetimibe 10 mg; atorvastatin calcium trihydrate 86,76 mg - eq. atorvastatin 80 mg - film-coated tablet - 10 mg - 80 mg - ezetimibe 10 mg; atorvastatin calcium trihydrate 86.76 mg - atorvastatin and ezetimibe

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

teva b.v. - rosuvastatin - film-coated tablet - 10 milligram(s) - hmg coa reductase inhibitors; rosuvastatin

Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - ezetimibe 10 mg; simvastatin 40 mg - tablet - 10 mg - 40 mg - ezetimibe 10 mg; simvastatin 40 mg - simvastatin and ezetimibe

Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - ezetimibe 10 mg; simvastatin 80 mg - tablet - 10 mg - 80 mg - ezetimibe 10 mg; simvastatin 80 mg - simvastatin and ezetimibe

Nhật Bản - Tiếng Anh - すりの適正使用協議会 RAD-AR Council, Japan

teva takeda pharma ltd. - ezetimibe - white tablet with 1/2 split line on one side, major axis: 8.2 mm, minor axis: 4.2 mm, thickness: 2.55 mm

Israel - Tiếng Anh - Ministry of Health

teva israel ltd - simvastatin - tablets - simvastatin 10 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvastatin-teva is indicated to: - reduce the risk of total mortality by reducing coronary death - reduce the risk of non-fatal myocardial infarction - reduce the risk for undergoing myocardial revascularization procedures.- reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvastatin-teva is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvastatin-teva therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios.homozygous familial hypercholesterolemia: simvastatin-teva is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertriglyceridemia (fredrickson type iv hyperlipidemia). simvastatin-teva is indicated for the treatment of patients with primary dysbetalipoproteinemia (fredrickson type iii hyperlipidemia).

Canada - Tiếng Anh - Health Canada

sanis health inc - ezetimibe - tablet - 10mg - ezetimibe 10mg - cholesterol absorption inhibitors

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

golden state medical supply, inc. - ezetimibe (unii: eor26lqq24) (ezetimibe - unii:eor26lqq24), simvastatin (unii: agg2fn16ev) (simvastatin - unii:agg2fn16ev) - ezetimibe 10 mg - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. ezetimibe and simvastatin tablets are indicated for the reduction of elevated total cholesterol (total-c), low-density lipoprotein cholesterol (ldl-c), apolipoprotein b (apo b), triglycerides (tg), and non-high-density lipoprotein cholesterol (non-hdl-c), and to increase high-density lipoprotein cholesterol (hdl-c) in patients with primary (heterozygous familial and non-familial) hyperlipidemia or mixed hyperlipidemia. ezetimibe and simvastatin tablets are indicated for the reduction of elevated total-c and ldl-c in patients with homozygous familial hypercholesterolemia, as an adjunct to other lipid-lowering treatments

Singapore - Tiếng Anh - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - atorvastatin calcium 10.36mg corresponding to atorvastatin - tablet, film coated - 10 mg - atorvastatin calcium 10.36mg corresponding to atorvastatin 10 mg